VIEMED HEALTHCARE, INC.VMDEarnings & Financial Report
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
Revenue
$50.6M
Gross Profit
$29.8M
Operating Profit
$2.2M
Net Profit
$1.6M
Gross Margin
58.9%
Operating Margin
4.4%
Net Margin
3.2%
YoY Growth
27.9%
EPS
$0.04
Financial Flow
VIEMED HEALTHCARE, INC. Q1 2024 Financial Summary
VIEMED HEALTHCARE, INC. reported revenue of $50.6M (up 27.9% YoY) for Q1 2024, with a net profit of $1.6M (up 5.7% YoY) (3.2% margin). Cost of goods sold was $20.8M, operating expenses totaled $27.6M.
Key Financial Metrics
| Total Revenue | $50.6M |
|---|---|
| Net Profit | $1.6M |
| Gross Margin | 58.9% |
| Operating Margin | 4.4% |
| Report Period | Q1 2024 |
VIEMED HEALTHCARE, INC. Annual Revenue by Year
VIEMED HEALTHCARE, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $270.3M).
| Year | Annual Revenue |
|---|---|
| 2025 | $270.3M |
| 2024 | $224.3M |
| 2023 | $183.0M |
| 2022 | $138.8M |
VIEMED HEALTHCARE, INC. Quarterly Revenue & Net Profit History
VIEMED HEALTHCARE, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $76.2M | +25.5% | $5.6M | 7.4% |
| Q3 2025 | $71.9M | +24.0% | $3.5M | 4.9% |
| Q2 2025 | $63.1M | +14.7% | $3.2M | 5.0% |
| Q1 2025 | $59.1M | +16.9% | $2.6M | 4.4% |
| Q4 2024 | $60.7M | +19.6% | $4.3M | 7.1% |
| Q3 2024 | $58.0M | +17.4% | $3.9M | 6.7% |
| Q2 2024 | $55.0M | +26.9% | $1.5M | 2.7% |
| Q1 2024 | $50.6M | +27.9% | $1.6M | 3.2% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.6M | $55.0M | $58.0M | $60.7M | $59.1M | $63.1M | $71.9M | $76.2M |
| YoY Growth | 27.9% | 26.9% | 17.4% | 19.6% | 16.9% | 14.7% | 24.0% | 25.5% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $154.9M | $163.9M | $169.5M | $177.1M | $178.1M | $184.6M | $202.4M | $199.2M |
| Liabilities | $38.6M | $42.8M | $42.7M | $43.8M | $41.3M | $43.0M | $66.9M | $55.6M |
| Equity | $116.3M | $119.4M | $125.0M | $131.4M | $134.8M | $139.7M | $133.6M | $141.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $1.2M | $10.2M | $12.7M | $15.0M | $2.9M | $12.3M | $18.4M | $18.4M |